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Background: As bacteria-originated crude violacein, a natural indolocarbazole product, consists of violacein and
deoxyviolacein, and can potentially be a new type of natural antibiotics, the reconstruction of an effective metabolic
pathway for crude violacein (violacein and deoxyviolacein mixture) synthesis directly from glucose in Escherichia coli
was of importance for developing industrial production process.
Results: Strains with a multivariate module for varied tryptophan productivities were firstly generated by combinatorial
knockout of trpR/tnaA/pheA genes and overexpression of two key genes trpEfbr/trpD from the upstream tryptophan
metabolic pathway. Then, the gene cluster of violacein biosynthetic pathway was introduced downstream of the
generated tryptophan pathway. After combination of these two pathways, maximum crude violacein production
directly from glucose by E. coli B2/pED + pVio was realized with a titer of 0.6 ± 0.01 g L−1 in flask culture, which
was four fold higher than that of the control without the tryptophan pathway up-regulation. In a 5-L bioreactor
batch fermentation with glucose as the carbon source, the recombinant E. coli B2/pED + pVio exhibited a crude
violacein titer of 1.75 g L−1 and a productivity of 36 mg L−1 h−1, which was the highest titer and productivity reported
so far under the similar culture conditions without tryptophan addition.
Conclusion: Metabolic pathway analysis using 13C labeling illustrated that the up-regulated tryptophan supply
enhanced tryptophan metabolism from glucose, whereas the introduction of violacein pathway drew more carbon
flux from glucose to tryptophan, thereby contributing to the effective production of crude violacein in the engineered
E. coli cell factory.
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Violacein is a natural indolocarbazole product obtained
from bacteria, which could potentially be a new type of
natural antibiotic [1] owing to its promising bioactivities
such as antibacterial [2], antitumoral [3], antiviral [4],
trypanocidal [5], antiprotozoan [6], and antioxidant ac-
tivities [7]. Since both violacein and deoxyviolacein have
the similar acid/alkali resistance, UV resistance and
antibacterial activity [8], the mass production of crude* Correspondence: chongzhang@mail.tsinghua.edu.cn;
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unless otherwise stated.violacein (mixture of violacein and deoxyviolacein) with
an adequate quantity at low cost is of significant
importance.
In previous studies, Chromobacterium violaceum,
Duganella sp., and Janthinobacterium lividum were iso-
lated for violacein production, which exhibited violacein
titers of 1.1, 1.62, and 0.85 g L−1, respectively [3,9,10].
However, the wild violacein producers were found to form
non-violacein-producing variants at a high frequency
during culture and subculture, which was one of the key
limiting factors for their industrial application [6], also,
C. violaceum and J. lividum were also find to be potential
pathogens which limit their industrial application [11,12].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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way in industrially acceptable hosts for stable and high
production of violacein in either crude or pure form has
been attracting increasing attention.
Citrobacter freundii and Enterobacter aerogenes [6]
had been employed as hosts for the reconstruction of
violacein biosynthetic pathway in our group. Among them,
C. freundii could achieve the highest titer of 4.12 g L−1
crude violacein with the addition of 2.8 g L−1 tryptophan
in fed-batch fermentation [13]. However, owing to the
high cost of tryptophan (an essential amino acid), engin-
eering of strains for violacein production from cheaper
carbon sources is desirable from an economic viewpoint.
Furthermore, C. freundii is a rare but infective bacterial
strain and its genome has not been sequenced, thus lead-
ing to the difficulties in genetic optimization. Therefore, a
completely genetically defined and industrially acceptable
host could provide more opportunities for pathway engin-
eering. Recently, Rodrigues et al. used systems metabolic
engineering to successfully reconstruct a violacein produc-
tion pathway in Escherichia coli, and achieved a pure
violacein titer of 0.71 g L−1 from arabinose [14] and a pure
deoxyviolacein titer of 1.6 g L−1 from glycerol [15] in a
fed-batch fermentation without the addition of trypto-
phan. However, the violacein and deoxyviolacein product-
ivity of the engineered E. coli by the direct utilization of
sugar or glycerol is still low (2 and 8 mg L−1 h−1, respect-
ively) [14,15], when compared with that achieved from
tryptophan of external addition using other recombinant
strains such as C. freundii [13]. Moreover, the use of
arabinose as the carbon source for the recombinant E. coli
is unsuitable for industrial application from an economic
viewpoint. To the best of our knowledge, no successful
trials have been conducted to reconstruct the violacein
biosynthetic pathway in E. coli for crude or pure violacein
production directly from glucose without the addition of
tryptophan.
Violacein biosynthetic pathway was first studied by
Pemberton et al. [16] and was completely elucidated by
Balibar et al. [17] and Sanchez et al. [18] in 2006. Tryp-
tophan, as a substrate for the synthesis of violacein, is
catalyzed by VioA to form indole-3-pyruvic acid, which
is then converted to protodeoxyviolacein acid by VioB
and VioE, followed by the catalysis of VioD and VioC to
form violacein and deoxyviolacein as the dominant
product and byproduct, respectively. With regard to the
metabolic engineering of a long pathway with indigenous
precursor supply and target metabolite synthesis, the
whole pathway can always be separated into several
modules for further optimization [19], which will facili-
tate the design and control of the interactive pathways
to achieve high titer of the target metabolite [20,21]. For
the construction of efficient violacein biosynthetic path-
way from glucose, tryptophan could be the key node forseparating the upstream and downstream pathways. Pre-
vious studies have found that the addition of tryptophan
to the medium can increase violacein production by both
violacein-producing wild strains and recombinant strains
[13,22]. In addition, Rodrigues et al. [14] also demon-
strated that an increase in the supply of tryptophan
through pathway engineering could benefit violacein
production from arabinose by E. coli. However, to date,
the way in which the violacein biosynthetic pathway
could affect the upstream tryptophan pathway remains
unknown. Thus, a modular approach with tryptophan
as the key node for the violacein biosynthetic pathway
could be a useful metabolic engineering strategy to achieve
high violacein production by E. coli from glucose as the
carbon source.
In the present study, deregulated trpEfbr and trpD
genes were introduced into E. coli mutants with com-
binatorial knockout of gene(s) trpR/pheA/tnaA to gener-
ate strains with different tryptophan productivities.
Subsequently, the vio gene cluster (vioABCDE) for viola-
cein biosynthetic pathway was introduced into the engi-
neered strains with multivariate tryptophan pathway to
examine their combinatorial effects on violacein produc-
tion from glucose. Then, the optimum strain with the
highest violacein titer was chosen for further analysis.
Metabolic pathway analysis using 13C labeling was per-
formed to elucidate the carbon flux change in the path-
way network. The tryptophan yield was also estimated to
uncover the pulling of the upstream pathway (trypto-
phan pathway) by the downstream pathway (violacein
pathway). Subsequently, batch fermentation of the
optimized recombinant strain in a 5-L bioreactor was
performed using glucose as the carbon source to dem-
onstrate the potential of the high violacein producer.
Results
Generation of strains with multivariate tryptophan
pathway module
The tryptophan biosynthetic pathway has been well
studied in E. coli and Corynebacterium glutamicum.
The pathway starts with the condensation of phospho-
enolpyruvate (PEP) and erythrose 4-phosphate (E4P), and
then forms chorismate, followed by the tryptophan branch
pathway to form tryptophan. In addition, phenylalanine
and tyrosine branches also exist, which compete for chor-
ismate to form phenylalanine and tyrosine [23]. The meta-
bolic flow of tryptophan pathway is always controlled
by tryptophan feedback inhibition, attenuation, and
repression (Figure 1) [23]. Thus, it is possible to gener-
ate tryptophan-accumulating strains by rational design
such as 1) enhancing the activity of key enzymes in the
common pathway to form chorismate and tryptophan
operon to improve pathway metabolic flux and 2) deleting
genes from chromosome that are responsible for the
Figure 1 Plasmid construction and gene knockout related to tryptophan accumulation. The black dotted line indicates repression. The red
cross indicates the target genes to be knocked out. The pink and blue colors indicate the upstream pathway of tryptophan accumulation, which was
improved, and the downstream pathway of violacein production from tryptophan, which was introduced, respectively. E4P, erythrose 4-phosphate;
PEP, phosphoenolpyruvate; DS, 3-deoxy-D-arabinoheptulosonate 7-phosphate synthase; DAHP, 3-deoxy-D-arabinoheptulosonate 7-phosphate; CM,
chorismate mutase; CA, chorismic acid; Phe, phenylalanine; Tyr, tyrosine; Trp, tryptophan; Vio, violacein, Devio, deoxyviolacein.





B1 E. coli BL21(DE3) wild type Laboratory
stock
B2 E. coli BL21(DE3) ΔtrpR This study
B3 E. coli BL21(DE3) ΔtrpR ΔpheA This study
B4 E. coli BL21(DE3) ΔtnaA This study
B5 E. coli BL21(DE3) ΔtnaA ΔpheA This study
B6 E. coli BL21(DE3) ΔtrpR ΔtnaA This study
B7 E. coli BL21(DE3) ΔpheA This study





pED pACYCDuet with trpEfbr (Met293Thr, TCC to
TTC; Ser40Leu ATG to ACG) and trpD genes
in NcoI and KpnI sites
This study
pVio pRSFduet with vio gene cluster in NdeI and
XhoI sites
This study
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of transcription of tryptophan operon (trpR), competi-
tion of chorismate to form other aromatic amino acid
(pheA), and degradation of tryptophan (tnaA) [23-25].
The multivariate module for various tryptophan-
producing strains were generated by combining the over-
expression of trpEfbr (feedback inhibition removed by
point mutation Met293Thr and Ser40Leu) and trpD under
T7 promoter, which are reported to be the key genes to
enhance tryptophan synthesis [23] and combinatorial
knockout of trpR, tnaA, and pheA, generating eight
different BL21(DE3) strains, B1–B8, possibly having dif-
ferent capabilities of producing tryptophan (Table 1).
The eight engineered strains were subsequently cultivated
in flasks with optimized culture medium (Additional file 1:
Table S2, Table S3 and Table S4) for tryptophan accumula-
tion, as shown in Figure 2. B6/pED and B8/pED showed
the highest tryptophan concentration (around 0.18 g L−1),
while B2/pED and B3/pED were the second highest
tryptophan-producing strains, and B1/pED were the low-
est tryptophan producers.
Combination of upstream and downstream pathways for
violacein production
The plasmids pACYCDuet-trpEfbr/trpD(pED) and pRSFDuet-
vio (pVio) were co-transformed into the strains B1–B8,
generating eight engineered strains, while the B1 strain
transformed only with pVio was used as the control.
These nine strains were cultivated in 100-mL flasks con-
taining the optimized medium (Additional file 1: Table S2,
Table S3 and Table S4) for violacein production. After the
flask culture, the crude violacein concentration and OD600
value were measured. From Figure 3, it can be noted
that 1) when compared with the control strain contain-
ing only pVio, the strains harboring the two plasmids,which contained the upstream and downstream path-
ways exhibited 3–4-fold higher violacein titers, and 2)
strains of B1-B8 which contained two plasmids (pED
and pVio) shared similar violacein titers and the titers
did not correlate well to the order of tryptophan pro-
duction by the strains containing only one plasmid
(pED) (Figure 3 vs. Figure 2), suggesting that the trypto-
phan pathway of poor-tryptophan producers had the
possibilities to be activated to supply enough precursor
when the downstream pathway for violacein synthesis
was docked. The crude violacein produced by B2/pED +
Figure 2 Production of tryptophan in flask culture with M9-YE medium (10 g L−1 glucose) at 20°C for 48 h (n=3).
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higher than that produced by the control strain B1/pVio
(0.153 ± 0.005 g L−1) (Figure 3). The OD600 value indicated
that B1/pVio showed higher cell density than B1/pED +
pVio, B2/pED+ pVio and other strains with the two plas-
mids; however, the strain with higher cell density did not
produce higher violacein concentration. Additional file 1:
Table S5 also showed the fermentation result of the B1
strain with the empty plasmid pACYCDuet and pVio,
its performance was similar with B1/pVio, indicating
that the lower biomass of strains with the two plasmids
was not caused by the addition of antibiotics. Moreover,
the tolerance of E. coli Bl21(DE3) to exogenously added
crude violacein showed that even the crude violacein
concentration was as high as 4.0 g L−1, the growth ofFigure 3 Production of crude violacein in flask culture with M9-YE meBl21(DE3) was not influenced (Figure 4), which was
consistence with previous report [8] that violacein and
deoxyviolacein did not inhibit cell growth of E. coli. It
suggested that the lower cell densities of B1/ pED +
pVio and B2/pED + pVio were not caused by the tox-
icity of crude violacein produced.
Analysis of the 13C incorporation rate of the metabolites
in central metabolism and tryptophan pathway of B2/
pED + pVio and B1/pVio
To explain the differences in the phenotypes of B2/pED +
pVio and B1/pVio (control), the dynamic 13C incorpor-
ation rate of the intermediates was monitored through a
13C-tracing experiment (D-Glucose-6-13C was initially
used as the carbon source). The time course of the 13Cdium (10 g L−1 glucose) at 20°C for 48 h (n=3).
Figure 4 The tolerance of E. coli Bl21(DE3) to exogenously added crude violacein (violacein and deoxyviolacein mixture) (n=3).
Fang et al. Microbial Cell Factories  (2015) 14:8 Page 5 of 13incorporation rate of the intermediates was first deter-
mined to find a relatively steady state, i.e. the middle expo-
nential phase, where the pool size is thought to be stable,
the 13C incorporation rate of a metabolite only depends
on its flux, and the higher incorporation rate means
higher flux goes through that intermediates [26]. It was
found that after 20 min of culture in 13C plate, the total
13C incorporation rates of most of the intermediates were
nearly steady (Additional file 1: Figure S7A); thus, a
culture period of 20 min was chosen for the subsequent
analysis. As shown in Figure 5, the total 13C incorporation
rates of the intermediates involved in the glycolysis path-
way, such as G-6-P/F-6-P (fructose-6-phosphate/glucose-6-
phosphate), F-1,6-bis-P (fructose-1,6-bisphosphate), 2-PG/
3-PG (2-phosphoglycerate/3-phosphoglycerate) and PEP
(phosphoenolpyruvate), were relatively lower for B2/pED +
pVio, when compared with those for the control strain B1/
pVio, indicating the lower glucose uptake rate of B2/pED +
pVio. As to the fermentation in 20 ml flask, the real glu-
cose uptake rate of B1/pVio (3.25 mg h−1) was higher than
that of B2/pED + pVio (1.21 mg h−1) which confirmed the
result of the 13C incorporation rate. The intermediates in-
volved in the TCA cycle and the related intermediates
such as acetyl-CoA and aspartate shared similar 13C in-
corporation rates in both strains. The pattern was also ob-
served for serine and E4P, which were precursors for
tryptophan synthesis. However, the other two important
precursors, chorismate and shikimate, were not detected
by LC-MS or GC-MS even with a modified extraction
method (data not show). With regard to the long pathway
from glucose to tryptophan, as an important precursor for
violacein synthesis, another 13C-tracing experiment wasemployed using D-glucose-13C6 as the carbon source to
focus on the 13C incorporation rate of tryptophan. The
results obtained suggested that the metabolic rate of tryp-
tophan observed for B2/pED + pVio was higher than that
for B1/pVio (Figure 5). In addition, the labeling pattern
of other metabolites, including glycine, phenylalanine,
and tyrosine in the branch pathway was similar between
B2/pED + pVio and B1/pVio.Change in the tryptophan and tryptophan equivalent yields
of the strains after introduction of violacein biosynthetic
pathway
The total tryptophan yield of four strains B1/pED, B2/
pED, B1/pED + pVio, and B2/pED + pVio were deter-
mined to further explore the change in the carbon flux
after reconstruction of violacein pathway. The four strains
were cultivated in flasks under the same conditions at
20°C for 48 h for tryptophan or violacein synthesis.
Since no tryptophan was detected in the strain of B1/
pED + pVio and B2/pED + pVio, the crude violacein
production of them was converted into tryptophan
equivalents, as described in the Material and Methods
Section. As shown in Table 2, after the reconstruction of
violacein pathway, the tryptophan yields of both B1/pED +
pVio and B2/pED + pVio were significantly increased when
compared with those of B1/pED and B2/pED (0.13 vs.
0.0004 and 0.38 vs. 0.024, a 300- and 15-fold dramatic
increase in tryptophan equivalent yield, respectively),
indicating the powerful pulling effect of the downstream
violacein biosynthesis pathway on the upstream precur-
sor supply.
Figure 5 The 13C incorporation rates of different metabolites for B2/pED+pVio and B1/pVio at 20 min. G-6-P/F-6-P, fructose-6-phosphate/
glucose-6-phosphate; F-1,6-bis-P, fructose-1,6-bisphosphate; 2-PG/3-PG, 2-phosphoglycerate/3-phosphoglycerate; PEP, phosphoenolpyruvate; E4P,
erythrose 4-phosphate (n=3).
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From the results of the flask culture described earlier, it
can be concluded that B2/pED + pVio was the most po-
tential strain for violacein production. This conclusion
was further examined by performing fermentation in a 5-
L bioreactor. Batch fermentation was conducted by online
control of the bioreactor containing 2 L of M9-YE
medium with 30 g L−1 glucose. When the OD600 reached
0.8, the temperature was changed from 37°C to 20°C, and
induction was performed with the addition of 0.05 mM
IPTG. The time course profiles of OD600, glucose concen-
tration, and crude violacein concentration were measured.
After induction, violacein started to accumulate during
the exponential growth phase, high violacein production
stability was noted, and non-violacein-producing variants
or low-yield mutants never appeared (data not shown).
These findings are in contrast to those reported in a pre-
vious study, which demonstrated that recombinant E. coli
with vio gene cluster exhibited high frequency of forming
non-violacein-producing variants or low-yield mutants







B1/pED 8.2±0.2 0.0024±0.0005 -
B2/pED 8.0±0.2 0.12±0.03 -
B1/pED+pVio 7.6±0.3 - 0.60±0
B2/pED+pVio 2.9±0.3 - 0.68±0violacein was found to be transported extracellularly and
occur as crystal-like forms, which might reduce product
toxicity and ensure the high titer (Additional file 1: Figures
S5 and S6). The secretion of violacein into the broth to
form pellets presumably enhanced the high violacein pro-
duction. As shown in Figure 6, B2/pED + pVio underwent
sigmoid growth and the final OD600 reached around 7.
Violacein began to accumulate after around 10 h of in-
duction, and the final violacein concentration reached
1.75 g L−1 at 48 h (with productivity of 36 mg L−1 h−1
and a yield from glucose = 0.116 g-violacein/g-glucose,
15.1 g L−1 glucose consumed), which is 4.48-fold higher
than that of C. freundii (pCom10vio) under the similar
culture conditions without tryptophan addition [13].
Discussion
Upstream up-regulation to improve precursor supply, a
commonly used strategy in metabolic engineering, can
result in an increase in the production of target metabo-
lites, especially those that are synthesized by exogenous









.01 1.6±0.4 0.078±0.03 0.13±0.01
.01 1.6±0.3 0.21±0.03 0.38±0.01
Figure 6 The time course profiles of batch fermentation of the engineered B2/pED+pVio in 5-L bioreactor containing 2 L of M9-YE
medium (30 g L−1 glucose) under controlled pH and dissolved oxygen level (n=3).
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duction from glucose, with a productivity (36 mg L−1 h−1)
and yield (0.116 g-vioalcein/g-glucose) exceeding most vio-
lacein/deoxyviolacein-producing strains under the similar
conditions without tryptophan addition reported so far
(Table 3). The violacein yield from glucose was estimated
to be 0.116 g-violacein/g-glucose, which corresponded
to a tryptophan equivalent yield of 0.136 g-tryptophan/
g-glucose, as high as 60% of theoretical maximum yield of
tryptophan (the theoretical maximum yield of tryptophan
toward glucose was 0.227 g-tryptophan/g-glucose) [27].
Although previous studies have shown that violacein pro-
duction may be inhibited when using glucose as the car-
bon source [28], in the present study, we achieved a high
crude violacein production from glucose. Rodrigues et al.
recently reported a successful production of pure violacein
and deoxyviolacein by pathway modification from arabin-
ose and glycerol, respectively [15,29]. Since both of viola-
cein and deoxyviolacein have the similar acid/alkali
resistance, UV resistance and antibacterial activity [8], we
aimed at the pathway engineering for the production of
crude violacein (mixture of violacein and deoxyviolacein)
directly from glucose in the present study. The pathway
engineering demonstrated by Rodrigues et al. [15,29] for
production of the pure violacein and deoxyviolacein can
be a good strategy for the further work on design of the
pure violacein or deoxyviolacein synthesis from different
carbon sources.
A multivariate tryptophan supply module was developed
to study their influences on downstream violacein produc-
tion. The strains B8, B6, B2, and B3, which shared the
same trpR gene knockout, showed the highest tryptophantiters. This was owing to that product of trpR gene could
mediate the repression of genes relevant to tryptophan
biosynthesis included in the aroG and trp operon [23,30].
As tnaA encodes tryptophanase and pheA encodes the en-
zyme for the biosynthesis of tyrosine and phenylalanine,
after the knockout of tnaA and/or pheA tryptophan accu-
mulations exhibited obvious increase but lower than those
of strains with trpR gene knockout (Figure 2). As these
three genes have different influences on the accumulation
of tryptophan [24,25,30-32], their combinatorial knockout
created multivariate tryptophan titers. After combining
with the downstream pathway, B2/pED + pVio was se-
lected as the best producer. The 13C labeling analysis dem-
onstrated that the glucose uptake rate was lower for B2/
pED + pVio, when compared with that for B1/pVio. We
suggested that the PEP, which plays important role in
phosphotransferase system for glucose uptake, was con-
sumed as the precursor for tryptophan synthesis (as shown
in Additional file 1: Figure S8A), and this resulted in lower
glucose uptake rate in B2/pED + pVio. While the carbon
flux to tryptophan supply, as a branch to compete the
carbon flux to form cell biomass, was increased for
B2/pED + pVio than that for B1/pVio on average (Figure 5).
Thus lower biomass accumulation in B2/pED + pVio was
due to 1) the lower glucose uptake rate and 2) less carbon
flux to biomass synthesis. Rodrigues et al. [14] also intensi-
fied tryptophan supply for violacein production and used
the intracellular tryptophan concentration to identify the
supply limitation. In the present study, we used 13C label-
ing analysis with higher resolution [33] to prove the in-
fluences of precursor supply on the downstream pathway.
To achieve further increase in violacein production, the
Table 3 The titers of the reported violacein-producing strains
Strain Carbon source Violacein and/or











C.violaceum 0.43 36 0.012 Flask culture 0.2 g L−1 [22]
1.1 30-L bioreactor batch
fermentation
[3]
Duganella sp. 1.62 32 0.050 Flask culture 0.74 g L−1 [9]
J.lividum 15 g L−1 sucrose 0.85 144 0.006 Flask culture Non 0.057 g g−1 [10]
Recombinant strains
C.freundii/pCOM10vio 0.75 40 0.019 Flask culture Non [6]
1.68 40 0.042 Flask culture 0.7 g L−1 [6]
5.67 g L−1 glycerol 0.47 35 0.013 5-L bioreactor batch
fermentation
Non 0.083 g g−1 [13]
0.95 35 0.027 5-L bioreactor batch
fermentation
0.7 g L−1 [13]
E.coli BL21(DE3)/
pET32avio
0.12 40 0.003 Flask culture Non [6]
E.coli MG1655-Vio4 0.71 300 0.002 0.7-L Fed-batch Non [14]
E.coli MG1655-Vio4 10 g L−1 arabinose 0.32 225 0.001 Flask culture Non [14]
MG1655-dVio8 1.6 200 0.008 Fed-batch Non 0.032 g g−1 [15]
E.coli Bl21(DE3)
B2/pED+pVio
15.1 g L−1 glucose 1.75 48 0.036 5-L bioreactor batch
fermentation










Fang et al. Microbial Cell Factories  (2015) 14:8 Page 9 of 13overexpression of aroG [27] and serA [14] genes or modi-
fication of phosphoenolpyruvate phosphotransferase sys-
tem for glucose uptake [34] might enable more transfer of
the carbon flux from central metabolism to tryptophan
synthesis.
We interestingly found that the introduction of down-
stream violacein biosynthetic pathway obviously enhanced
the tryptophan flux. After docking with the downstream
pathway, a respective 300- and 15-fold dramatic increase
in upstream tryptophan equivalent yield for the two se-
lected strains was observed, quantitatively proving the
presence of pulling effect, which means that the carbon
flux of upstream was increased due to consumption of me-
tabolites by downstream pathway. In this study, the pulling
effect was mainly owing to alleviation of inhibitory regula-
tion, which resulted in decreased loss of carbon flux to the
branched pathways and enhanced the tryptophan supply to
violacein synthesis. TnaA, pheA, and trpR play roles in de-
grading tryptophan, competing carbon flux from trypto-
phan and inhibiting the transcription of trp operon when
tryptophan accumulated, while when the downstream
pathway for violacein synthesis was docked, less typtophan
was accumulated, thus decreasing the effect of knockout of
tnaA, pheA and trpR. This could explain why strain B1
with pED and pVio is already a suitable producer of crude
violacein. Previous studies had used multivariate modules
with different transcriptional or translational levels to ex-
plore a balanced module as precursor supply [19,35]. Thus,
the pulling effect on these cases was hard to be found obvi-
ously as 1) this effect may not exited in these situations
and/or 2) the yields of the precursor and target chemicals
were not compared quantitatively to find this effect [19,35].
In the present study, we demonstrated that the down-
stream violacein biosynthetic pathway could obviously
draw the carbon flux of the upstream pathway to produce
more precursors from glucose. This kind of interactive pull
effect was possible to occur when the accumulated metab-
olites was consumed effectively by a docked pathway and
finally resulted in self-balancing of the long pathway, which
dynamically drew more, but not excess, precursor for the
downstream pathway to achieve high productivity of the
target products.
Material and methods
Bacterial strains and culture medium
E. coli DH5α (Invitrogen) was used for plasmid con-
struction. The E. coli strains and plasmids used in this
study are listed in Table 1. Luria-Bertani (LB) medium
was used as the complex medium and modified M9-YE
medium (17.1 g L−1 Na2HPO4, 3 g L
−1 KH2PO4, 0.5 g L
−1
NaCl, 1 g L−1 NH4Cl, 1 g L
−1 Yeast Extract, 1 mMMgSO4,
and 0.1 mM CaCl2) [36] containing glucose as the carbon
source was used for tryptophan or violacein production
(the glucose concentration was 10 g L−1 unless stated).This medium was proved to be sufficient to support
growth of all the strains. Kanamycin (50 μg mL−1) and/or
chloromycetin (34 μg mL−1) were added when needed. A
100-mL flask containing 20 mL of M9-YE medium was
used for violacein fermentation, and glucose and IPTG
(Isopropyl β-D-1-Thiogalactopyranoside) were added as
the carbon source and inducer, respectively.
P1 transduction
JW 3686, JW 4356, and JW 2580 were obtained from
the National BioResource Project-E. coli (National Insti-
tute of Genetics, Mishima, Japan). P1 transduction was
used to construct the gene deletion mutants of BL21
(DE3) by knocking out tnaA, trpR, and pheA genes sep-
arately or in combination to generate eight different
gene types of BL21(DE3) [37]. Three makers ΔtnaA::
FRT-kan-FRT, ΔtrpR::FRT-kan-FRT and ΔpheA::FRT-kan-
FRT, were transduced from E. coli K strain JW 3686, JW
4356, and JW 2580, respectively. Then, the helper plas-
mid pCP20 [38,39] containing a temperature-sensitive
origin replication and thermally inducible FLP gene was
transformed into this strain, followed by induction to re-
move the kan maker. Specific primers listed in Additional
file 1: Table S1 confirmed the implementation and valid-
ation for genetic modification.
Construction of pACYCDuet-trpEfbr/trpD and pRSFDuet-vio
The E. coli W3110 genomic DNA was extracted with
Bacteria Genomic DNA Purification Kit (Tiangen, Beijing)
and used as a template for the amplification of trpED
with Primer Star polymerase (Takara, Japan) and primers
NcoI-trpE-F/AflII-trpD-R (Additional file 1: Table S1).
Point mutation was conducted (Met293Thr, TCC to TTC;
Ser40Leu, ATG to ACG) according to the previous report
[40] to reduce feedback inhibition. After digestion by NcoI
and AflII, the fragment was ligated to NcoI/AflII-digested
pACYCDuet. The plasmid pCom10-vio [6] was used as a
template for the amplification of the vio gene cluster with
two pairs of primers AseI-vio1-F/NotI-vio1-R and Not-
vio2-F/XhoI-vio2-R (Additional file 1: Table S1). The two
fragments were digested by AseI/NotI and NotI/XhoI,
respectively, and ligated to NdeI/XhoI-digested pRSFDuet.
Genes of trpEfbr/trpD and vio gene cluster were both
under the control of IPTG-inducible T7 promoter.
Analytical method
For the measurement of tryptophan, after fermentation,
the supernatants were filtered through 0.22-μm mem-
brane filters for HPLC analysis. The samples were sepa-
rated in a Inertsil ODS-SP 4.6 × 250 mm column with
methanol (A) and 0.05% H3PO4 in water (B) as the mobile
phase and a detector set to a wavelength of 280 nm
(0–3 min, 2% A; 3–30 min, 2%–80% A; 30–40 min, 80%
A; 40–50 min, 80%–2% A; and 50–60 min, 2% A). For the
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culture broth was centrifuged and the crude violacein in
the pellet was extracted with ethanol. After total extrac-
tion, the pellet was centrifuged again, and the absorbance
of the crude violacein solution at 570 nm (Abs570) was
measured to determine the concentration of crude viola-
cein (Additional file 1: Figure S4) and the ratio between
violacein and deoxyviolacein remained constant during
the fermentation [29]. Subsequently, the pellet was resus-
pended in deionized water prior to measurement of the
optical density at 600 nm, as described previously [6,13].
The molecular weight of violacein and deoxyviolacein
was detected by TOF (Time Of Flight) LC/MS Sys-
tem (Waters, Xevo G2), which demonstrated that the pur-
ple pigment was violacein and deoxyviolacein mixture
(Additional file 1: Figures S1 and S2). The composition of
violacein and deoxyviolacein was determined by HPLC
with a Inertsil ODS-SP 4.6 × 150 mm column, 75% metha-
nol in water as the mobile phase, and a detector set to a
wavelength of 570 nm (Additional file 1: Figure S3). The
crude violacein of this composition was dried to detect
the relationship between Abs570 and crude violacein con-
centration (Additional file 1: Figure S4). During fermenta-
tion, the residual glucose concentration in the medium
was detected by the DNS (dinitrosalicylic acid) method
[41], and the pH of the samples was determined by using
HORIBA B-712 pH meter.
The tolerance of E.coli to crude violacein
Effect of crude violacein on the growth of E. coli was
examined by external addition of crude violacein into
the culture. The E. coli Bl21(DE3) cultures of exponential
phase were diluted 1:100 to the fresh M9-YE medium with
10 g L−1 glucose. Crude violacein was added at the same
time using DMSO (dimethylsulfoxide) as co-solvent to a
final concentration of 0 (DMSO only), 0.25, 0.50, 1.00,
2.00 or 4.00 g L−1. These cultures were then cultivated at
37°C for 24 hours. Then, the culture broth was centrifuged
and the crude violacein in the pellet was extracted with
ethanol. After total extraction, the pellet was resuspended
in deionized water prior to measurement of the optical
density at 600 nm for evaluation of the cell growth.
13C labeling analysis
Metabolic pathway analysis by 13C labeling was per-
formed by using the following protocol based on the
method reported by Yang et al. [26]. Metabolites such
as D-glucose-6-13C (one carbon C6 was 13C labeled),
D-glucose-13C6 (six carbons were
13C labeled), acyl-CoAs,
amino acids, organic acids, and sugar phosphates were
obtained from Sigma (St. Louis, MO, USA). The bacterial
cells were grown in M9-YE medium with 12C glucose
(5 g L−1) as the carbon source. In the middle of the expo-
nential phase (OD600 = 0.70–0.80), 8 mL of the culturewere extracted and rapidly passed through the membrane
filter (0.22 μm, 47 mm, Sartorius) using a pipette. The
filter was immediately removed and placed on an agar
plate of M9-YE medium with 12C glucose for 20 min, and
then transferred to another agar plate with the same
concentration of 13C glucose. At defined time points, the
filter was immediately transferred to a 15-mL tube with
liquid nitrogen for quenching. The sample was stored
at −80°C for subsequent extraction.
The metabolites extraction method was modified ac-
cording to the previous procedure reported by Yang et al.
[26]. Briefly, 2 mL of hot extraction buffer (60%, v/v
ethanol/water, 1 mM EDTANa2, and 5 mM ammonium
acetate) were added to the sample and incubated at 80°C
for 3 min. The extracted suspension was centrifuged at
5000 × g for 5 min to remove cell debris. Subsequently, the
suspension was centrifuged again at 13,000 × g for 15 min,
and the supernatant was dried in a vacuum centrifuge
(Christ, RVC 2–18 CD plus, Germany). For LC-MS ana-
lysis, the dried sample was dissolved in 100 μL of aceto-
nitrile/water (1:1, v/v) and analyzed on an Agilent 6460
system. For separation on an Acquity UPLC BEH Amide
(Waters) column, the mobile phase A was acetonitrile/
water (2:98,v/v), 0.2% formic acid, and 0.1% ammonium hy-
droxide, and the mobile phase B was acetonitrile/water
(95:5,v/v), 0.1% formic acid, and 0.075% ammonium hy-
droxide. For the metabolites detected in the positive ESI
mode, the following linear gradient was used: 0–0.5 min,
100% B; 0.5–5.5 min, 100%–81% B; 5.5–11 min, 81%–72% B;
11–16 min, 72%–40% B; 16–17 min, 40%–100% B; and
17–29 min, 100% B. For the metabolites detected in the
negative mode, the following linear gradient was used:
0–4 min, 100% B; 4–21 min, 100%–72% B; 21–26 min,
72%–40% B; 26–27 min, 40%–100% B; and 27–40 min,
100% B. The total run time was 29 and 40 min at
0.2 mL min−1, respectively. The injection volume was
10 μL for both methods. The LC-MS/MS experiments
were conducted as described previously [26]. The dwell time
for each MRM (multiple reaction monitoring) transition
was 16 s. All the peaks were integrated using the Qualitative
Analysis B.05.00 software. The total 13C incorporation of a
metabolite with N carbon atoms was calculated by normal-
izing to its total carbon number according to the previous
protocol [26] as shown in Eq. (1) and Eq. (2).
Mi %ð Þ ¼ miPn
j¼0 mj
ð1Þ
Total13C incorporation %ð Þ ¼
PN
i¼ i  Mið Þ
N
ð2Þ
where mi represented the isotopic abundance for a me-
tabolite in which the i 13C atoms were incorporated and
n represented the maximum number of 13C atoms
incorporated.
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yields from glucose
The medium used in this experiment was M9-YE with
10 g L−1 glucose and 0.05 mM IPTG was used for induc-
tion. Glucose consumption was calculated by detecting
the concentration of glucose in the medium (the carbon
source from yeast extraction was ignored). The dry cell
weight was calculated using Eq. (3) according to OD600.
The ash content and composition of the biomass was es-
timated to 5.5% and CH1.8O0.5 N0.2 (molecular weight of
biomass (Mbiomass) = 24.6) as E. coli K-12, respectively
[33]. For the tryptophan producer, the actual tryptophan
concentration was mainly contributed by the extracellular
concentration as detected by HPLC, and hence, intracellu-
lar tryptophan concentration could be ignored. The peak
areas of violacein and deoxyviolacein produced in the
present study were similar (Additional file 1: Figure S3),
and their extinction coefficients were 0.074 and 0.048 L mg
−1 cm−1 respectively [29]. As no pure violacein and deoxy-
violacein were available, violacein and deoxyviolacein were
estimated to account for 39% and 61% of the crude viola-
cein, respectively. The tryptophan concentration equivalent
for the violacein producers was calculated according to vio-
lacein titer as expressed by Eq. (4). Incidentally, in all of the
violacein producers, the residual tryptophan could not be
detected (data not shown), which indicated that the trypto-
phan synthesized by the upstream pathway was quickly
converted to violacein inside the cells. Thus, the C-mol bio-
mass, tryptophan, and tryptophan equivalent yields were
calculated according to Eq. (5), (6), and (7), respectively.
Dry cell weight g L‐1






crude violacein concentration 39%
Mviolacein
þ crude violacein concentration  61%
Mdeoxviolacein

 Mtryptophan  2
ð4Þ
C‐molbiomassyield
¼ Dry cell weight gL
‐1
   1‐5:5%ð Þ=Mbiomass
Glucose consumption gL‐1
 
=Mglu cose  6
ð5Þ
C‐mol tryptophanyield
¼ tryptophan concentration gL
‐1
   =Mtryptophan  11
Glucose consumption gL‐1
 
=Mglu cose  6
ð6ÞC‐mol tryptophanequivalent yield






=Mglu cose  6
ð7Þ
where Mviolacein, Mdeoxyviolacein, Mtryptophan, Mbiomass and
Mglucose represent the molecular weight of violacein, deox-
yviolacein, tryptophan, biomass and glucose, respectively.
Fermentation kinetics of the engineered strain B2/pED+pVio
The engineered strain B2/pED+pVio was incubated at 37°C
and 200 rpm overnight in LB broth with kanamycin
(50 μg mL−1) and chloromycetin (34 μg mL−1). Subse-
quently, 5% inoculum (100 mL for 2 L) was added into
2 L of fresh M9-YE medium containing 30 g L−1 glucose
in a 5-L stirred tank bioreactor (Sartorius, Germany).
The temperature was initially controlled at 37±0.1°C
and then at 20±0.1°C after the induction according to
our previous report [6,8-10,13]. The induction was per-
formed with 0.05 mM IPTG when the OD600 value of the
culture reached 0.8 and the temperature of the culture
was shifted to 20°C. The dissolved oxygen level was con-
trolled above 25±5% with Inpro 6800/12/320 O2 sensor
(Mettler Toledo). The pH of the culture was controlled at
7.0±0.5 using 405-DPAS-SC-K8S/325 pH electrode and
10 M NaOH/3 M HCl. The samples were withdrawn
during fermentation to measure the concentration of
glucose, crude violacein, and cell density (OD600).
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generated generated from Figure S7A. Figure S8. Theoretical maximum
yield of tryptophan toward glucose in absence of constant maintenance
energy requirement. The numbers indicate the relative flux carried by the
reactions. 8A, the theoretical maximum yield of tryptophan generated
under common situation (0.20 molar yield); 8B, the theoretical maximum
yield of tryptophan generated when the PTS is not taken into account
(0.40 molar yield). 8C, the theoretical maximum yield of tryptophan
generated when pyruvate is recycled back to PEP (0.59 molar yield).
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